1. Elbini Dhouib I, et al. A minireview on N-acetylcysteine: An old drug with new approaches. Life Sci. 2016 Apr 15;151:359-63.
2. Mokhtari V, et al. A Review on Various Uses of N-Acetyl Cysteine. Cell J. 2017; 191(1):11-17.
3. Whyte IM, et al. Safety and efficacy of intravenous N-acetylcysteine for acetaminophen overdose: analysis of the Hunter Area
Toxicology Service (HATS) database. Curr Med Res Opin. 2007 Oct;23(10):2359-68.
4. de Andrade KQ, et al. Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine.
Int J Mol Sci. 2015 Dec 18:16(12):30269-308.
5. Millea PJ. N-acetylcysteine: multiple clinical applications. Am Fam Physician. 2009 Aug 1;80(3):265-9.
6. Sadowska AM, et al. Role of N-acetylcysteine in the management of COPD. Int J Chron Obstruct Pulmon Dis. 2006;1(4):425-34.
7. Rasmussen JB, Glennow C. Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in
patients with chronic bronchitis. Eur Respir J. 1988 Apr;1(4):351-5.
8. De Flora S, et al. Attenuation of infuenza-like symptomatology and improvement of cell-mediated immunity with long-term
N-acetylcysteine treatment. Eur Respir J. 1997;10(7):1535-1541.
9. Makipour K, Friedenberg FK. The Potential Role of N-Acetylcysteine for the Treatment of Helicobacter pylori. J Clin Gastroenterol.
2011 Nov-Dec; 45(10): 841–843.
10. Minarini A, et al. N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects. Expert Opin Drug
Metab Toxicol. 2017 Mar;13(3):279-292.
11. Back SE, et al. A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress
Disorder and Substance Use Disorders. J Clin Psychiatry. 2016 Nov;77(11):e1439-e1446.